Silence Therapeutics plc

SLN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001479615

SEC filings (opens in a new tab)

No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.

Other share classesSLNCF

Q1 2024 vs. Q4 2023

How the institutions holding Silence Therapeutics plc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of SLN: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	34	64	+30
Shares	20.5M	27.7M	+7.18M (+35.0%)
Value	$343.9M	$588.0M	+$244.1M (+71.0%)

New holders (32)

Institutions that held Silence Therapeutics plc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SLN in Q1 2024
Institution	Shares	Value	% of portfolio
Redmile Group, LLC	2,027,669	$43.8M	1.61%
Nextech Invest AG	952,400	$20.6M	3.26%
Janus Henderson Group PLC	625,864	$13.6M	0.01%
Cormorant Asset Management, LP	625,000	$13.5M	0.59%
Adage Capital Partners GP, L.L.C.	600,000	$13.0M	0.02%
Polar Capital Holdings Plc	500,000	$10.8M	0.07%
5AM Venture Management, LLC	476,200	$10.3M	2.30%
Millennium Management LLC	409,418	$8.84M	0.01%
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	387,400	$8.37M	0.22%
Mangrove Partners	385,408	$8.32M	0.72%
Octagon Capital Advisors LP	315,000	$6.80M	0.83%
Hudson Bay Capital Management LP	276,590	$5.97M	0.05%
Nantahala Capital Management, LLC	200,000	$4.32M	0.42%
Marshall Wace, LLP	139,191	$3.01M	0.00%
Boothbay Fund Management, LLC	127,224	$2.75M	0.08%
Two Sigma Investments, LP	107,212	$2.32M	0.01%
Walleye Capital LLC	91,819	$1.98M	0.02%
BIT Capital GmbH	89,000	$1.92M	0.17%
Two Sigma Advisers, LP	77,400	$1.67M	0.00%
Artia Global Partners LP	52,476	$1.13M	0.28%
Cubist Systematic Strategies, LLC	36,281	$783.7K	0.01%
Goldman Sachs Group Inc	21,739	$469.6K	0.00%
Trexquant Investment LP	21,047	$454.6K	0.01%
Rathbone Brothers plc	19,906	$430.0K	0.00%
Jump Financial, LLC	18,800	$406.1K	0.01%
Shay Capital LLC	15,150	$327.2K	0.10%
NEOS Investment Management LLC	11,656	$251.8K	0.02%
Advisor Group Holdings, Inc.	10,922	$235.8K	0.00%
JPMorgan Chase & Co	9,610	$207.6K	0.00%
Point72 Asset Management, L.P.	8,200	$177.1K	0.00%
Barclays PLC	5,570	$120.3K	0.00%
Advisors Preferred, LLC	1,109	$24.1K	0.00%

Sold out (2)

Institutions that held Silence Therapeutics plc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of SLN in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
BVF Inc	1,508,416	$26.2M
Tower Research Capital LLC (TRC)	707	$12.3K